ERBB2 and idiopathic pulmonary fibrosis: Blocking the HER2 signaling with pertuzumab markedly inhibited lung fibrosis in a humanized mouse fibrosis model, suggesting that the HER2 signaling may be a key driver of fibroblast invasion and progressive lung fibrosis and may be a novel therapeutic target in IPF.